BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34278498)

  • 1. Abnormal function of telomere protein TRF2 induces cell mutation and the effects of environmental tumor‑promoting factors (Review).
    Wang Z; Wu X
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcusone C induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2.
    Wang M; Cao J; Zhu JY; Qiu J; Zhang Y; Shu B; Ou TM; Tan JH; Gu LQ; Huang ZS; Yin S; Li D
    Biochim Biophys Acta Proteins Proteom; 2017 Nov; 1865(11 Pt A):1372-1382. PubMed ID: 28870734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-PKcs-interacting protein KIP binding to TRF2 is required for the maintenance of functional telomeres.
    Khadka P; Lee JH; Baek SH; Oh SY; Chung IK
    Biochem J; 2014 Oct; 463(1):19-30. PubMed ID: 25012820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA.
    Stagno D'Alcontres M; Mendez-Bermudez A; Foxon JL; Royle NJ; Salomoni P
    J Cell Biol; 2007 Dec; 179(5):855-67. PubMed ID: 18056407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the TRF2 telomeric protein in cancer and ageing.
    Muñoz P; Blanco R; Blasco MA
    Cell Cycle; 2006 Apr; 5(7):718-21. PubMed ID: 16582635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle-dependent 3D distribution of telomeres and telomere repeat-binding factor 2 (TRF2) in HaCaT and HaCaT-myc cells.
    Ermler S; Krunic D; Knoch TA; Moshir S; Mai S; Greulich-Bode KM; Boukamp P
    Eur J Cell Biol; 2004 Dec; 83(11-12):681-90. PubMed ID: 15679112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of TRF2 induce telomeric ultrafine anaphase bridges and rapid telomere deletions.
    Nera B; Huang HS; Lai T; Xu L
    Nat Commun; 2015 Dec; 6():10132. PubMed ID: 26640040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere shortening and expression of TRF1 and TRF2 in uterine leiomyoma.
    Oh BK; Choi Y; Choi JS
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Intra- and Extra-Telomeric Role of TRF2 in the DNA Damage Response.
    Imran SAM; Yazid MD; Cui W; Lokanathan Y
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Quindoline derivative with telomeric repeat-containing RNA induces telomeric DNA-damage response in cancer cells through inhibition of telomeric repeat factor 2.
    Zhang Y; Zeng D; Cao J; Wang M; Shu B; Kuang G; Ou TM; Tan JH; Gu LQ; Huang ZS; Li D
    Biochim Biophys Acta Gen Subj; 2017 Dec; 1861(12):3246-3256. PubMed ID: 28943299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The shelterin protein TRF2 inhibits Chk2 activity at telomeres in the absence of DNA damage.
    Buscemi G; Zannini L; Fontanella E; Lecis D; Lisanti S; Delia D
    Curr Biol; 2009 May; 19(10):874-9. PubMed ID: 19375317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRF2-independent chromosome end protection during pluripotency.
    Ruis P; Van Ly D; Borel V; Kafer GR; McCarthy A; Howell S; Blassberg R; Snijders AP; Briscoe J; Niakan KK; Marzec P; Cesare AJ; Boulton SJ
    Nature; 2021 Jan; 589(7840):103-109. PubMed ID: 33239783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere attrition and chromosome instability via downregulation of TRF2 contributes to arsenic trioxide-induced apoptosis of human T-Cell leukemia cell line molt-4 cells.
    Jiao Y; Zhang W; Liu J; Ni W; Xu W; Jin J; Qian W
    Cancer Biol Ther; 2007 Aug; 6(8):1186-92. PubMed ID: 17643074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRF2 recruits ORC through TRFH domain dimerization.
    Higa M; Kushiyama T; Kurashige S; Kohmon D; Enokitani K; Iwahori S; Sugimoto N; Yoshida K; Fujita M
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):191-201. PubMed ID: 27836746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mathematical model of cellular apoptosis and senescence through the dynamics of telomere loss.
    Arkus N
    J Theor Biol; 2005 Jul; 235(1):13-32. PubMed ID: 15833310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRF2 dysfunction elicits DNA damage responses associated with senescence in proliferating neural cells and differentiation of neurons.
    Zhang P; Furukawa K; Opresko PL; Xu X; Bohr VA; Mattson MP
    J Neurochem; 2006 Apr; 97(2):567-81. PubMed ID: 16539655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRF2-mediated ORC recruitment underlies telomere stability upon DNA replication stress.
    Higa M; Matsuda Y; Fujii J; Sugimoto N; Yoshida K; Fujita M
    Nucleic Acids Res; 2021 Dec; 49(21):12234-12251. PubMed ID: 34761263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRF2 promotes multidrug resistance in gastric cancer cells.
    Ning H; Li T; Zhao L; Li T; Li J; Liu J; Liu Z; Fan D
    Cancer Biol Ther; 2006 Aug; 5(8):950-6. PubMed ID: 16760674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Mobility Group A2 protects cancer cells against telomere dysfunction.
    Natarajan S; Begum F; Gim J; Wark L; Henderson D; Davie JR; Hombach-Klonisch S; Klonisch T
    Oncotarget; 2016 Mar; 7(11):12761-82. PubMed ID: 26799419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRF2 controls telomeric nucleosome organization in a cell cycle phase-dependent manner.
    Galati A; Magdinier F; Colasanti V; Bauwens S; Pinte S; Ricordy R; Giraud-Panis MJ; Pusch MC; Savino M; Cacchione S; Gilson E
    PLoS One; 2012; 7(4):e34386. PubMed ID: 22536324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.